Optimization of a transient antibody expression platform towards high titer and efficiency.


Journal

Biotechnology journal
ISSN: 1860-7314
Titre abrégé: Biotechnol J
Pays: Germany
ID NLM: 101265833

Informations de publication

Date de publication:
Apr 2021
Historique:
revised: 10 11 2020
received: 29 05 2020
pubmed: 24 11 2020
medline: 28 4 2021
entrez: 23 11 2020
Statut: ppublish

Résumé

Transient gene expression (TGE) using mammalian cells is an extensively used technology for the production of antibodies and recombinant proteins and has been widely adopted by both academic and industrial labs. Chinese Hamster Ovary (CHO) cells have become one of the major workhorses for TGE of recombinant antibodies due to their attractive features: post-translational modifications, adaptation to high cell densities, and use of serum-free media. In this study, we describe the optimization of parameters for TGE for antibodies from CHO cells. Through a matrix evaluation of multiple factors including inoculum, transfection conditions, amount and type of DNA used, and post-transfection culture conditions, we arrived at an uniquely optimized process with higher titer and reduced costs and time, thus increasing the overall efficiency of early antibody material supply. We further investigated the amount of coding DNA used in TGE and the influence of kinetics and size of the transfection complex on the in vitro efficiency of the transfection. We present here the first report of an optimized TGE platform using Filler DNA in an early drug discovery setting for the screening and production of therapeutic mAbs.

Identifiants

pubmed: 33226178
doi: 10.1002/biot.202000251
doi:

Substances chimiques

Recombinant Proteins 0
Polyethyleneimine 9002-98-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2000251

Informations de copyright

© 2021 Wiley-VCH GmbH.

Références

Geisse, S. (2009). Reflections on more than 10 years of TGE approaches. Protein Expr. Purif., 64, 99-107.
Bandaranayake, A. D., & Almo, S. C. (2014). Recent advances in mammalian protein production. FEBS Lett., 588, 253-260.
Ye, J., Kober, V., Tellers, M., Naji, Z., Salmon, P., & Markusen, J. F. (2009). High-level protein expression in scalable CHO transient transfection. Biotechnol. Bioeng., 103, 542-551.
Gutierrez-Granados, S., Cervera, L., Kamen, A. A., & Godia, F. (2018). Advancements in mammalian cell transient gene expression (TGE) technology for accelerated production of biologics. Crit. Rev. Biotechnol., 38, 918-940.
Arena, T. A., Harms, P. D., & Wong, A. W. (2018). High Throughput Transfection of HEK293 Cells for Transient Protein Production. Methods Mol. Biol., 1850, 179-187.
Rajendra, Y. (2018). PEI-Mediated Transient Gene Expression in CHO Cells. Methods Mol. Biol., 1850, 33-42.
Li, F., Vijayasankaran, N., Shen, A. Y., Kiss, R., & Amanullah, A. (2010). Cell culture processes for monoclonal antibody production. MAbs, 2, 466-479.
Stuible, M., Burlacu, A., Perret, S., Brochu, D., Paul-Roc, B., Baardsnes, J., … Durocher, Y. (2018). Optimization of a high-cell-density polyethylenimine transfection method for rapid protein production in CHO-EBNA1 cells. J. Biotechnol., 281, 39-47.
Jäger, V., Büssow, K., Schirrmann, T., in: Al-Rubeai, M. (Ed.), Transient recombinant protein expression in mammalian cells, in Animal Cell Culture, Springer International Publishing, Switzerland 2015, pp. 27-64.
Castan, A., Schulz, P., Wenger, T., & Fischer, S., in: Jagschies, G., Lindskog, E., Łącki, K., Galliher, P. (Eds.), Biopharmaceutical Processing Development, Design, and Implementation of Manufacturing Processes, Elsevier, The Netherlands 2018, pp. 97-146.
Bronzino, J. D., & D. R. Peterson, The Biomedical Engineering Handbook: Molecular, Cellular, and Tissue Engineering, CRC Press, Taylor & Francis Group, Boca Raton, FL 2015.
Gronemeyer, P., Ditz, R., & Strube, J. (2014). Trends in upstream and downstream process development for antibody manufacturing. Bioengineering, 1, 188-212.
Schlatter, S., Stansfield, S. H., Dinnis, D. M., Racher, A. J., Birch, J. R., & James, D. C. (2005). On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO Cells. Biotechnol. Prog, 21.
Liu, C., Dalby, B., Chen, W., Kilzer, J. M., & Chiou, H. C. (2008). Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells. Mol. Biotechnol., 39, 141-153.
Bos, A. B., Duque, J. N., Bhakta, S., Farahi, F., Chirdon, L. A., Junutula, J. R., … Wong, A. W. (2014). Development of a semi-automated high throughput transient transfection system. J. Biotechnol., 180, 10-16.
Moore, A., Mercer, J., Dutina, G., Donahue, C., Bauer, K., Mather, J., … Ryll, T. (1997). Effects of temperature shift on cell cycle, apoptosis and nucleotide pools in CHO cell batch cultues. Cytotechnology, 23, 47-54.
Wulhfard, S., Tissot, S. P., Bouchet, S., Cevey, J., De Jesus, M., Hacker, D. L., & Wurm, F. M. (2008). Mild hypothermia improves transient gene expression yields several fold in chinese hamster ovary cells. Biotechnol. Prog., 24, 458-465.
Kaufmann, H., Mazur, X., Fussenegger, M., & Bailey, J. E. (1999). Influence of low temperature on productivity, proteome and protein phosphorylation of CHO cells. Biotechnol. Bioeng., 63, 573-582.
de Los Milagros Bassani Molinas, M., Beer, C., Hesse, F., Wirth, M., & Wagner, R. (2014). Optimizing the transient transfection process of HEK-293 suspension cells for protein production by nucleotide ratio monitoring. Cytotechnology, 66, 493-514.
Zhao, Q., Chen, J., Lv, T., He, C., Tang, G., Liang, W., … Gao, J. (2009). N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex. Biol. Pharm. Bull., 32, 706-710.
Lee, Y. K., Brewer, J. W., Hellman, R., & Hendershot, L. M. (1999). BiP and immunoglobulin light chain cooperate to control the folding of heavy chain and ensure the fidelity of immunoglobulin assembly. Mol. Biol. Cell, 10, 2209-2219.
Ho, S. C., Koh, E. Y., van Beers, M., Mueller, M., Wan, C., Teo, G., … Yang, Y. (2013). Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability. J. Biotechnol., 165, 157-166.
Bollin, F., Dechavanne, V., & Chevalet, L. (2011). Design of experiment in CHO and HEK transient transfection condition optimization. Protein Expr. Purif., 78, 61-68.
Sunley, K., & Butler, M. (2010). Strategies for the enhancement of recombinant protein production from mammalian cells by growth arrest. Biotechnol. Adv., 28, 385-394.
Rajendra, Y., Balasubramanian, S., Kiseljak, D., Baldi, L., Wurm, F. M., & Hacker, D. L. (2015). Enhanced plasmid DNA utilization in transiently transfected CHO-DG44 cells in the presence of polar solvents. Biotechnol. Prog., 31, 1571-1578.
Pradhan, K., & Gadgil, M. (2012). Effect of addition of 'carrier' DNA during transient protein expression in suspension CHO culture. Cytotechnology, 64, 613-622.
Peng, L., Xiong, W., Cai, Y., Chen, Y., He, Y., Yang, J., … Li, H. (2017). A simple, rapid method for evaluation of transfection efficiency based on fluorescent dye. Bioengineered, 8, 225-231.
Estes, B., Hsu, Y. R., Tam, L. T., Sheng, J., Stevens, J., & Haldankar, R. (2015). Uncovering methods for the prevention of protein aggregation and improvement of product quality in a transient expression system. Biotechnol. Prog., 31, 258-267.

Auteurs

Elizabeth Greene (E)

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Daniela Cazacu (D)

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Ninkka Tamot (N)

Janssen Biotherapeutics, Spring House, Pennsylvania, USA.

Steven Castellano (S)

Duke University School of Medicine, Durham, North Carolina, USA.

Akshita Datar (A)

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Anthony Kronkaitis (A)

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Douglas Gebhard (D)

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Jon Reed (J)

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Paul Mawson (P)

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Lore Florin (L)

Bristol Myers Squibb, Redwood City, California, USA.

Nicholas Rossi (N)

MirusBio LLC, Madison, Wisconsin, USA.

Anthony Lauer (A)

MirusBio LLC, Madison, Wisconsin, USA.

Laura Juckem (L)

MirusBio LLC, Madison, Wisconsin, USA.

Andrew Nixon (A)

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Till Wenger (T)

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Saurabh Sen (S)

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH